🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...
Status
Completed
Location
Saint Louis University - Center for Vaccine Development
Start Date
2018-08-15
Trial ID
NCT03553940
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
This is a Phase Ib study in healthy adults (18-70 years) to evaluate the sa...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2012-08
Trial ID
NCT01676402
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
The purpose of this research study is to evaluate the immune response to th...
Status
Completed
Location
Univ. of Alabama Birmingham NICHD CRS (5096)
Start Date
2009-10
Trial ID
NCT01484522
This study will evaluate the safety and immunogenicity in healthy children ...
Status
Completed
Location
Centro de Atención e Investigación Medica - CAIMED
Start Date
2010-09
Trial ID
NCT01209780
Treatments Being Tested
This research study involves testing of a device that can give injections (...
Status
Completed
Location
University of Maryland College Park Health Center
Start Date
2010-01
Trial ID
NCT00987350
Treatments Being Tested
A Phase 3, randomized, observer-blinded, active-controlled trial to evaluat...
Status
Completed
Location
US135
Start Date
2019-10-14
Trial ID
NCT04120194
Treatments Being Tested
The primary objectives of this study are to evaluate the humoral immunogeni...
Status
Completed
Location
CEI -Centro de Estudios Infectológicos
Start Date
2022-06-06
Trial ID
NCT05415462
Treatments Being Tested
This study is a Phase 1, 2-part, randomised, double-blind, controlled, clin...
Status
Completed
Location
Lis Gilmour, Senior Project Manager
Start Date
2022-04-11
Trial ID
NCT05223179
Treatments Being Tested